Aakaar Medical Technologies to List on NSE SME on 27 June After 2.28× Oversubscribed IPO

Mumbai, 26 June 2025: Aakaar Medical Technologies Ltd is scheduled to make its market debut on the NSE Emerge platform on Friday, 27 June 2025, following a robust investor response to its ₹27 crore initial public offering (IPO). The issue, which closed on 24 June, was subscribed 2.28 times, highlighting notable demand from institutional, non-institutional, and retail participants.

Final IPO Subscription Status as on 24 June

By the end of bidding at 6:19 PM on 24 June, the IPO attracted 57,00,800 bids against an available 24,96,000 shares, with a total of 1,637 applications received across all categories.

Category-Wise Subscription:

Category	Shares Offered	Shares Bid For	Subscription	Applications
QIB	7,12,000	24,96,000	3.51x	7
NII	5,36,000	7,93,600	1.48x	123
Retail	12,48,000	24,11,200	1.93x	1,507
Total	24,96,000	57,00,800	2.28x	1,637

---

Issue Structure and Capital Deployment

The IPO, amounting to ₹27 crore, is a purely fresh issue comprising 37.5 lakh equity shares, with no offer-for-sale (OFS) involved. The proceeds are earmarked for business expansion and general corporate purposes, as outlined in the red herring prospectus.

Company Overview

Established in 2013 and based in Mumbai, Aakaar Medical Technologies Ltd is involved in the manufacturing of medical devices and dermatological ointments, with a primary focus on aesthetic treatment solutions. The company caters to a growing segment within the healthcare and cosmetic dermatology market.

Post-IPO Shareholding Pattern

Following allotment, the ownership of the company stands as follows:

• Promoters and Promoter Group hold 67.01% of the total equity share capital, with no encumbrances or pledged shares.
• Public Shareholding stands at 32.99%, comprising institutions, individuals, NRIs, AIFs, and HUFs.

Notably, alternate investment funds such as AARTH AIF Growth Fund and India Equity Fund hold stakes above 1% each, reflecting institutional confidence in the company.

REF: https://nsearchives.nseindia.com/content/equities/SHP_AAKAAR.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations